The Ambulatory Care Journey: From PGY2 to Practice
Release Date:11/21/2025 Expiration Date:11/21/2028 CE Credits: THERE IS NO CE ASSOCIATED WITH THIS ACTIVITY Activity Fee: Member – Free / Non-Member – Free
Activity Overview
This activity features a conversation amongst two current and two former PGY2 ambulatory care pharmacy residents to discuss their decision to pursue a second year residency, provide insight into their residency program structure and day-to-day experiences,share realistic strategies to manageresidency workload stressors,and comment on career aspirations and workforce readiness.
After completing this activity, the learner should be able to:
Describekey factors that influence pharmacists’ decisions to pursue a PGY2 ambulatory care pharmacy residency.
Explore the varying structures, expectations, and day-to-day experiences of PGY2 ambulatory care residency programs, and identify effective strategies to manage workload and stress during residency.
Discuss how PGY2 training supports career development and workforce readiness in ambulatory care pharmacy.
Canice Coan, PharmD, BCACP, DPLA Pharmacy Supervisor, Clinic Embedded Pharmacy Team PGY2 Ambulatory Care Pharmacy Residency Program Director Nebraska Medicine Omaha, NE
Natalie Schwenka, PharmD, BCACP Ambulatory Care Pharmacist Nebraska Medicine Omaha, NE
Bhavika Patel, PharmD, BCACP Ambulatory Care Pharmacist Parkview Health Fort Wayne, IN
Abigail (Abby) Drobny, PharmD PGY2 Ambulatory Care Pharmacy Resident Nebraska Medicine Omaha, NE
Joseph Loredo, PharmD PGY2 Ambulatory Care Pharmacy Resident Advocate Health Milwaukee, WI
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
